Biostax Corp (BTAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 407 | 313 | N/A |
| TOTAL | $623 | $313 | $N/A |
| Non-Current Assets | |||
| PPE Net | 6 | 1 | N/A |
| Intangibles | 18,547 | 18,688 | 0 |
| Other Non-Current Assets | 17 | 25 | 0 |
| TOTAL | $18,570 | $18,714 | $N/A |
| Total Assets | $19,192 | $19,027 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 817 | N/A | N/A |
| Accounts payable and accrued liabilities | 916 | 363 | 0 |
| Accrued Expenses | 588 | 427 | N/A |
| Other current liabilities | 118 | 200 | N/A |
| TOTAL | $2,440 | $1,422 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 121 | 121 | N/A |
| Other Non-Current Liabilities | 0 | 140 | 0 |
| TOTAL | $121 | $261 | $N/A |
| Total Liabilities | $2,561 | $1,683 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 84 | N/A | N/A |
| Common Shares | 7 | 46 | N/A |
| Retained earnings | -283,003 | -176,943 | N/A |
| Other shareholders' equity | -8,554 | -2,392 | 0 |
| TOTAL | $16,631 | $17,344 | $N/A |
| Total Liabilities And Equity | $19,192 | $19,027 | $0 |